Marksans Pharma shares rise 4% on ABCnow acquisition
after close1 source ↓written by the desknot a recommendation
- following the announcement
- 4%
- of ABCnow GmbH
- 100%
Shares of Marksans Pharma surged nearly 4% following the announcement of its acquisition of 100% of ABCnow GmbH, a German pharmaceutical company. The stock traded at ₹270 on the NSE, reaching an intraday high of ₹272. This acquisition enhances Marksans' access to regulated European markets, bolstering its forward-integration strategy.
Not investment advice. For informational purposes only.